Eagle Veterinary Technology
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Eagle Veterinary Technology makes and imports medicines for livestock and companion animals, including injectable drugs, water-soluble powders, feed additives, antibiotics, antiparasitic treatments, vitamins, and vaccines, used to prevent and treat disease in cattle, pigs, and poultry.
Its customers are livestock farmers and the broader Korean animal-husbandry supply chain. Listed on KOSDAQ, Korea's small-cap tech board, the company both manufactures and imports the full range of veterinary drug formats it supplies to the market.
Summary is AI-generated and may contain errors · figures from DART filings
Eagle Veterinary Technology in five facts
What does Eagle Veterinary Technology do?
Eagle Veterinary Technology makes and imports medicines for livestock and companion animals, including injectable drugs, water-soluble powders, feed additives, antibiotics, antiparasitic treatments, vitamins, and vaccines, used to prevent and treat disease in cattle, pigs, and poultry.
Where is Eagle Veterinary Technology listed and in which sector?
Eagle Veterinary Technology (Korean name: 이글벳) trades under KRX code 044960 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Industrials sector, Trading & Distribution.
How large is Eagle Veterinary Technology?
Its market capitalisation was US$29.3M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Eagle Veterinary Technology's latest annual revenue and operating profit?
For fiscal year 2025, Eagle Veterinary Technology reported revenue of US$32.7M, operating profit of US$3.2M and net income of US$3M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 3.9% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.